New opioid speeds up recovery without increasing pain sensitivity or risk of chronic pain
Tulane University researchers develop non-addictive painkiller that works as well as morphine but also diminishes inflammation, reduces recovery time and ...
Tag: Pharmaceutical Science
Rare pulmonary side effects of brigatinib often resolve without treatment discontinuation
Credit: University of Colorado Cancer Center Brigatinib is a next-generation ALK inhibitor that earned FDA approval in 2017 as a ...
Using 3D to test personalised treatments in five days
UNIGE researchers have developed a cell co-culture platform that can reproduce a patient's tumour in 3D and test the best ...
Exercise: Psych patients’ new primary prescription
Credit: David Tomasi BURLINGTON, VT -- When it comes to inpatient treatment of a range of mental health and mood ...
Study supports effectiveness of new fast-acting antidepressant, esketamine nasal spray
New research supports the effectiveness and safety of esketamine nasal spray in treating depression in people who have not responded ...
AJTMH tipsheet for May 2019
Credit: National Institute of Allergy and Infectious Diseases (NIAID); Rocky Mountain Laboratories, NIH California Study Warns Obscure Q Fever a ...
Potential new therapy takes aim at a lethal esophageal cancer’s glutamine addiction
Researchers at the Medical University of South Carolina have identified and exploited a metabolic Achilles heel in cancer--glutamine addiction. They ...
New method simplifies the search for protein receptor complexes, speeding drug development
Credit: Troye Fox For a drug to intervene in cells or entire organs that are not behaving normally it must ...
Record number of patients take part in clinical research
Credit: (c) NIHR https://www.eurekalert.org/pub_releases/2019-04/aafc-sfm042219.php The number of people benefiting from clinical research in England reached record highs this year - ...
Obesity medicine association announces major updates to its adult obesity algorithm
Updates help clinicians address chronic disease of obesity, identified as the most common cause of prevalent patient conditions DENVER -- ...
Yale study identifies how cancer drug inhibits DNA repair in cancer cells
New Haven, Conn. -- According to researchers at Yale Cancer Center, a cancer drug thought to be of limited use ...
Toy transformers and real-life whales inspire biohybrid robot
Heart tissue and 3D printing combine to build a microscopic motorCredit: City University of Hong Kong HANOVER, N.H. - May ...
New technology to revolutionize drug development
Collaboration aims to create 3D images of cells in high resolution The search for new drugs to combat diseases more ...
Clinical trial at IU School of Medicine improves treatment of genetic rickets
Credit: Indiana University School of Medicine A new study shows a drug developed in conjunction with investigators at Indiana University ...
GW researcher seeks to improve diagnostic utility of neonatal EEGs
Matthew Colonnese, PhD, has been awarded more than $4 million for study of early brain activity WASHINGTON (May 15, 2019) ...
Big data helps identify better way to research breast cancer’s spread
EAST LANSING, Mich. - Scientists are using a lot of genomic data to identify medical issues sooner in patients, but ...
China unlikely to curb fentanyl exports in short-term
Study outlines how some Asian nations are reforming illicit drug policies Strict policies traditionally embraced by Asian nations to discourage ...
Inappropriate prescribing can lead to adverse outcomes
In older adults, inappropriate prescribing in primary care is associated with a wide range of adverse outcomes, but not mortality. ...
In rural areas, buprenorphine is provided by primary care clinicians
As the United States undertakes intense efforts to increase the number of prescribers of buprenorphine for opioid use disorder, it ...
Learning more about opioid prescribing in primary care
Chronic opioid prescribing in primary care varies significantly by patient and clinician characteristics, according to a new study. Researchers at ...